Evidence map›Paper›PMID 42078934›Full record

ArticleFrontiers in pharmacology2026

Neuroprotective effect of standardized

Safa Abdelbaset, Iriny M Ayoub, Rasha A Tawfiq, Taghreed A Majrashi, Mahmoud A El Hassab, Wagdy Eldehna, Dina M El-Kersh, Omayma A Eldahshan

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Safa Abdelbaset *Pharmacognosy Department, Faculty of Pharmacy, The British University in Egypt (BUE), Cairo, Egypt.
Iriny M AyoubPharmacognosy Department, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt.
Rasha A TawfiqDrug Research and Development Group (DRD-G), The British University in Egypt (BUE), Cairo, Egypt.
Taghreed A MajrashiDepartment of Pharmacognosy, College of Pharmacy, King Khalid University, Abha, Saudi Arabia.
Mahmoud A El HassabDepartment of Medicinal Chemistry, Faculty of Pharmacy, King Salman International University (KSIU), El Tor, Egypt.
Wagdy EldehnaDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Kafrelsheikh University, Kafr ElShaikh, Egypt.
Dina M El-Kersh *Pharmacognosy Department, Faculty of Pharmacy, The British University in Egypt (BUE), Cairo, Egypt.
Omayma A EldahshanPharmacognosy Department, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Alzheimer's disease (AD), marked by gradual cognitive decline and memory deterioration, poses a major global health concern and ranks as the fourth leading contributor to disability-adjusted life years. Genus Methods: The neuroprotective assessment includes histopathological examination, behavior tests, and biochemical analysis, Results: The phytochemical investigations revealed the isolation of six compounds, Discussion: The neuroprotective evaluation using behavioral and biochemical analyses demonstrated dose-dependent neuroprotective effects of the defatted methanol extract, with the Conclusion: The findings of this study reveal the potential of the defatted methanolic extract and

Indexed as

acetylcholinesteraseAlzheimer’sELISAellman’s assayscopolamineVitex pubescens bark

Identifiers

PMID42078934
PMCPMC13132829

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.